Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime

The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below. The company should choose the form that corresponds to the schedule on which the importing country appears, as well as the patent status of the pharmaceutical product in that country. The application must be accompanied by a certified copy of the importing country's notification and any other declarations made by the country.

If the importing country appears on Schedule 2 and is a World Trade Organization (WTO) member, and the pharmaceutical product is not patented in that country, choose

• "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(i)(A) of the Patent Act"

If the importing country appears on Schedule 2 and is a WTO member, and the pharmaceutical product is patented in that country, choose

• "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(i)(B) of the Patent Act"

If the importing country appears on Schedule 2 and is not a WTO member, and the pharmaceutical product is not patented in that country, choose

• "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(ii)(A) of the Patent Act"

If the importing country appears on Schedule 2 and is not a WTO member, and the pharmaceutical product is patented in that country, choose

• "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(ii)(B) of the Patent Act"

If the importing country appears on Schedule 3 or Schedule 4, and the pharmaceutical product is not patented in that country, choose

• "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(iii)(A), (iv)(A) or (v)(A) of the Patent Act"